日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistance.

BET溴结构域抑制剂birabresib在套细胞淋巴瘤中的体内活性及克服适应性耐药性的新组合的鉴定

Tarantelli Chiara, Bernasconi Elena, Gaudio Eugenio, Cascione Luciano, Restelli Valentina, Arribas Alberto Jesus, Spriano Filippo, Rinaldi Andrea, Mensah Afua Adjeiwaa, Kwee Ivo, Ponzoni Maurilio MD, Zucca Emanuele, Carrassa Laura, Riveiro Maria E, Rezai Keyvan, Stathis Anastasios, Cvitkovic Esteban, Bertoni Francesco

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma

溴结构域抑制剂OTX015(MK-8628)与靶向药物联合使用,在淋巴瘤中显示出强大的体内抗肿瘤活性。

Gaudio, Eugenio; Tarantelli, Chiara; Ponzoni, Maurilio; Odore, Elodie; Rezai, Keyvan; Bernasconi, Elena; Cascione, Luciano; Rinaldi, Andrea; Stathis, Anastasios; Riveiro, Eugenia; Cvitkovic, Esteban; Zucca, Emanuele; Bertoni, Francesco

Spectrum of cellular responses to pyriplatin, a monofunctional cationic antineoplastic platinum(II) compound, in human cancer cells

吡啶铂(一种单功能阳离子抗肿瘤铂(II)化合物)在人类癌细胞中的细胞反应谱

Lovejoy, Katherine S; Serova, Maria; Bieche, Ivan; Emami, Shahin; D'Incalci, Maurizio; Broggini, Massimo; Erba, Eugenio; Gespach, Christian; Cvitkovic, Esteban; Faivre, Sandrine; Raymond, Eric; Lippard, Stephen J